Athenahealth May Drop to $110 Without Elliott Bid Says RBC
Athenahealth may suffer now that Elliott is reportedly backing off from its bid.

Ruh-roh.

On Monday, Sept. 18, The New York Post reported that Elliott Management, Paul Singer's hedge fund, is backing away from its $160-per-share bid for Athenahealth (ATHN) .

RBC analyst George Hill wrote, "absent the bid, we suspect Athenahealth shares could fall back to the $110-$120 range where they traded prior to the activist bid."

On Tuesday, Athenahealth was down 5% to around $135 a share in morning trading.

The bid for a total sum of $6.9 billion was first made in May. The Post reported that Elliott while backing away from the initial bid, may be interested in lowering the price. 

Athena's deadline for bidding is now Sept. 27, which is 10 days longer than the company originally offered. 

Elliott has taken an activist role in Athenahealth, forcing CEO Jonathan Bush out in June. 

In the past three months, shares of Athenahealth have dropped around 10%.

More from Markets

Dow Jumps on Signs of Progress in U.S.-China Trade Discussions

Dow Jumps on Signs of Progress in U.S.-China Trade Discussions

Tax Loss Selling Recovery Candidates, Part 2

Tax Loss Selling Recovery Candidates, Part 2

Microsoft, Amazon, Apple Are Top Holdings of U.S. Hedge Funds

Microsoft, Amazon, Apple Are Top Holdings of U.S. Hedge Funds

Workday Has Been Working Higher on the Charts - More Gains to Come

Workday Has Been Working Higher on the Charts - More Gains to Come

American Eagle Shares Rise After Company Issues Weak Guidance

American Eagle Shares Rise After Company Issues Weak Guidance